TickerFacts.

A business in context

TARS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K/A · Current report

    Report date 2026-09-04 · 0001819790-26-000069 · Items 9.01

  2. 4 · Ownership change

    Report date 2026-09-15 · 0001228684-26-000010

  3. 4 · Ownership change

    Report date 2026-09-15 · 0001181186-26-000008

  4. 4 · Ownership change

    Report date 2026-09-15 · 0001051578-26-000010

  5. 8-K · Current report

    Report date 2026-09-04 · 0001819790-26-000066 · Items 2.01,8.01,9.01

  6. 4 · Ownership change

    Report date 2026-09-04 · 0001842190-26-000011

  7. 4 · Ownership change

    Report date 2026-09-04 · 0001827672-26-000013

  8. 4 · Ownership change

    Report date 2026-09-04 · 0001827584-26-000013

  9. 4 · Ownership change

    Report date 2026-09-01 · 0001842190-26-000009

  10. 4 · Ownership change

    Report date 2026-09-02 · 0001827672-26-000011

  11. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001819790-26-000064

  12. 8-K · Current report

    Report date 2026-08-06 · 0001819790-26-000063 · Items 2.02,9.01

  13. 8-K · Current report

    Report date 2026-08-05 · 0001819790-26-000062 · Items 1.01,3.02,8.01,9.01

  14. 8-K · Current report

    Report date 2026-07-31 · 0001819790-26-000060 · Items 1.01,3.02,8.01,9.01

  15. 8-K · Current report

    Report date 2026-07-13 · 0001819790-26-000048 · Items 5.02

  16. 8-K · Current report

    Report date 2026-07-06 · 0001819790-26-000046 · Items 1.01,3.02,8.01,9.01

  17. 8-K · Current report

    Report date 2026-06-25 · 0001819790-26-000043 · Items 5.07

  18. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001819790-26-000038

  19. 8-K · Current report

    Report date 2026-05-06 · 0001819790-26-000037 · Items 2.02,9.01

  20. DEF 14A · Proxy statement

    Report date 2026-06-25 · 0001819790-26-000028

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001819790-26-000019

  22. 8-K · Current report

    Report date 2026-02-23 · 0001819790-26-000017 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2026-02-18 · 0001819790-26-000005 · Items 5.02,9.01

  24. 8-K · Current report

    Report date 2026-01-12 · 0001819790-26-000002 · Items 7.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001819790-25-000121

  26. 8-K · Current report

    Report date 2025-11-04 · 0001819790-25-000120 · Items 2.02,9.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001819790-25-000108

  28. 8-K · Current report

    Report date 2025-08-06 · 0001819790-25-000107 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2025-06-12 · 0001819790-25-000100 · Items 5.07

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001819790-25-000078

  31. 8-K · Current report

    Report date 2025-05-01 · 0001819790-25-000077 · Items 2.02,9.01

  32. DEF 14A · Proxy statement

    Report date 2025-06-12 · 0001819790-25-000070

  33. 8-K · Current report

    Report date 2025-03-14 · 0001819790-25-000035 · Items 8.01

  34. 8-K · Current report

    Report date 2025-03-12 · 0001193125-25-053978 · Items 1.01,8.01,9.01

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001819790-25-000011

  36. 8-K · Current report

    Report date 2025-02-25 · 0001819790-25-000007 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2025-01-15 · 0001819790-25-000003 · Items 5.02

  38. 8-K · Current report

    Report date 2025-01-13 · 0001193125-25-005030 · Items 7.01,9.01

  39. 8-K · Current report

    Report date 2024-12-16 · 0001819790-24-000138 · Items 1.01

  40. SC 13G/A · Ownership disclosure

    0001172661-24-005050

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 14 transaction rows14SGrant / award: 0 transaction rows0AExercise / conversion: 6 transaction rows6MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

20 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-15
2026-09-17
LINK WILLIAM J PHD
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock66.080.01
2026-09-15
2026-09-17
LINK WILLIAM J PHD
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock759.079.0
2026-09-15
2026-09-17
LINK WILLIAM J PHD
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11675.078.33
2026-09-15
2026-09-17
LINK WILLIAM J PHD
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock201.0n/a
2026-09-15
2026-09-17
LINK WILLIAM J PHD
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
201.00.0
2026-09-15
2026-09-17
YARNO WENDY LM · Exercise / conversion
Acquired
Common Stock302.0n/a
2026-09-15
2026-09-17
YARNO WENDY LM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
302.00.0
2026-09-15
2026-09-17
PYOTT DAVID E IM · Exercise / conversion
Acquired
Common Stock201.0n/a
2026-09-15
2026-09-17
PYOTT DAVID E IM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
201.00.0
2026-09-04
2026-09-09
Lin Elizabeth Yeu
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1590.085.0
2026-09-04
2026-09-09
Lin Elizabeth Yeu
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1590.090.0
2026-09-04
2026-09-09
Lin Elizabeth Yeu
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5387.085.0
2026-09-04
2026-09-09
Lin Elizabeth Yeu
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5386.090.0
2026-09-04
2026-09-09
Azamian Bobak R.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2900.091.27
2026-09-04
2026-09-09
Azamian Bobak R.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7100.090.27
2026-09-04
2026-09-09
Neervannan Seshadri
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4564.085.0
2026-09-02
2026-09-03
Lin Elizabeth Yeu
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1590.080.0
2026-09-02
2026-09-03
Lin Elizabeth Yeu
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5387.080.0
2026-09-02
2026-09-03
Azamian Bobak R.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10000.080.06
2026-09-01
2026-09-03
Lin Elizabeth Yeu
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4601.073.86

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001819790Tarsus Pharmaceuticals, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$182.95M$196.51M
    2023-12-31$17.45M$19.29M
    2022-12-31$25.82M$29.72M
    2021-12-31$57.03M$70.90M
    2020-12-31$0$0

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗